YSOPIA Bioscience Competitors and Similar CompaniesClear all
YSOPIA Bioscience's competitors and similar companies include BIOHM, EIP Pharma, WuXi AppTec and Molecular Partners.
 YSOPIA Bioscience YSOPIA Bioscience (formerly known as LNC Therapeutics) is a biotech company specializing in gut microbiome-based drug discovery. |  BIOHM BIOHM Health is a company that specializes in human digestive system microbiome testing and probiotics development. |  WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. | ||
Founding Date | Founding Date 2010 | Founding Date 2016 | Founding Date 2010 | Founding Date 2000 | Founding Date 2004 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Bordeaux, FR HQ | Locations Cleveland, US HQ Cleveland, US | Locations Cambridge, US HQ Boston, US | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US |
Employees | Employees 3 | Employees 274% increase | Employees 3 | Employees 39,414 | Employees 158 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥23.8b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ¥21.3b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ¥19.3b (FY, 2025) | Net income (CHF61.7m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 7.7m (over 8 years ago) | Latest funding round $ 7.5m (over 3 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 12.3m | Total funding raised $ 7.5m | Total funding raised $ 32.9m | Total funding raised $ 902.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
BIOHM
HQ
Cleveland, US
Employees
27↑ 4% increase
BIOHM Health is a company that specializes in human digestive system microbiome testing and probiotics development.
View company
EIP Pharma
HQ
Cambridge, US
EIP Pharma is a clinical-stage therapeutics company focused on CNS disorders.
View companyWuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View companyMolecular Partners
HQ
Zürich-Schlieren, CH
Employees
158
Molecular Partners is a company that develops biopharmaceutical products for serious diseases.
View company